NDC Labeler Bsp Pharmaceuticals Srl

Bsp Pharmaceuticals Srl labeler's code is 43624. The labeler has 21 products that have an assigned National Drug Code.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Product Type Status
43624-002Halaven Eribulin MesylateInjectionIntravenousHuman Prescription DrugACTIVE
43624-004 Loncastuximab TesirineInjection, Powder, Lyophilized, For SolutionDrug For Further ProcessingUNFINISHED
43624-005 Pemetrexed Disodium HeptahydratePowder, For SolutionDrug For Further ProcessingUNFINISHED
43624-006 Pemetrexed Disodium HeptahydratePowder, For SolutionDrug For Further ProcessingUNFINISHED
43624-007 BamlanivimabSolutionDrug For Further ProcessingUNFINISHED
43624-008 Sacituzumab GovitecanInjection, Powder, Lyophilized, For SolutionDrug For Further ProcessingUNFINISHED
43624-009 Bendamustine Hci InjectionInjection, SolutionDrug For Further ProcessingUNFINISHED
43624-010 Bendamustine Hci InjectionInjection, SolutionDrug For Further ProcessingUNFINISHED
43624-012 Mirvetuximab Soravtansine GynxInjectionDrug For Further ProcessingUNFINISHED
43624-013 Vestronidase Alfa-vjbkInjectionDrug For Further ProcessingUNFINISHED
43624-014 Enfortumab Vedotin-ejfv For InjectionInjectionDrug For Further ProcessingUNFINISHED
43624-015 TirzepatideInjection, SolutionDrug For Further ProcessingUNFINISHED
43624-016 TirzepatideInjection, SolutionDrug For Further ProcessingUNFINISHED
43624-017 TirzepatideInjection, SolutionDrug For Further ProcessingUNFINISHED
43624-018 TirzepatideInjection, SolutionDrug For Further ProcessingUNFINISHED
43624-019 TirzepatideInjection, SolutionDrug For Further ProcessingUNFINISHED
43624-020 TirzepatideInjection, SolutionDrug For Further ProcessingUNFINISHED
43624-021 Patritumab DeruxtecanInjection, Powder, Lyophilized, For SolutionDrug For Further ProcessingUNFINISHED
43624-022 Cedazuridine And DecitabineTablet, Film CoatedDrug For Further ProcessingUNFINISHED
43624-023 Enfortumab Vedotin-ejfv For InjectionInjectionDrug For Further ProcessingUNFINISHED
43624-024 Bortezomib 3.5mg/vialInjection, Powder, Lyophilized, For SolutionDrug For Further ProcessingUNFINISHED